Category Archives: Drugs

12 June 2013 Last updated at 11:09 ET A British man accused of a drugs conspiracy in the US must be extradited to stand trial without the public knowing his identity, the High Court has ruled. Two judges said the man, referred to as B, must not be named to protect his daughter from publicity. The court heard B, from west London, is the sole carer of the girl, 12, and extraditing him could "devastate" her. He is accused of importing and distributing crystal meth in New York. He is alleged to have been involved in organising deals - exporting from India between 2011 and 2012 - through multiple phone calls with a New York contact but never leaving the UK. His lawyers contended it was a case of entrapment. Refusing the man's appeal against extradition, the judges rejected his claim that his removal would cause a disproportionate breach of his daughter's right to a family life under Article 8 of the European Convention on Human Rights. They imposed reporting restrictions, saying the girl was facing a "deeply troubling" time and entitled to protection from media attention. Sir John Thomas, president of the Queen's Bench Division, sitting with Mr Justice … Continue reading →

Pregnant women should be included in clinical trials for drugs, experts have suggested. Pregnancy is a "natural state" which has been ignored by drugs companies for too long, according to an editorial in the Drug and Therapeutics Bulletin. Pharmaceutical companies should examine "safe" ways to involve pregnant women in trials for new medicines. Around one in 10 pregnant women have a chronic medical disorder that requires regular use of drugs, and others develop problems during pregnancy, the bulletin says. "The relative lack of information on the use of medicines during pregnancy remains an area of concern for healthcare professionals," the experts write. Some medics are afraid of causing harm to patients and some women are fearful of taking drugs while pregnant because there is little published evidence about the risks and benefits. "Although there are complex ethical issues associated with studying drugs in pregnant women, some researchers argue that it is unethical not to obtain dosing information for drugs that are frequently used by pregnant women," the editorial says. Follow this link: Drugs trials call for pregnant women … Continue reading →

This is what drugs do to your brain By: rashida plump … Continue reading →

drugs are bad for yall do drugs and you gonna get touched in your booty hole. By: mark zakem … Continue reading →

Why Novartis focuses on cancer drugs By: ChannelNewsful … Continue reading →

Drugs, Inc By: mekha narasimha … Continue reading →

Kimu on drugs LOLOLO.... Kimu was using a bit too much LSCatnip XD. By: DjBoyo01 … Continue reading →

Drugs and broom WTF Must See! Drugs and broom WTF Must See!Drugs and broom WTF Must See!Drugs and broom WTF Must See!Drugs and broom WTF Must See!Drugs and broom WTF Must See!Drugs and br... By: FootBallGuyHD … Continue reading →

NEW YORK, June 11, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Markets for Orphan Drugs http://www.reportlinker.com/p096587/Global-Markets-for-Orphan-Drugs.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication INTRODUCTION STUDY OBJECTIVES The orphan drug market is one of the fastest-growing segments in the pharmaceutical and biotechnology industry. BCC's goal in conducting this study is to provide an overview of the current and future global market for orphan drugs. The key objective is to present a comprehensive analysis of current orphan drugs and those under development as important therapies and treatments for rare diseases. This report explores present and future strategies and regulations within the orphan drug market, advances in the market, the setbacks, the current situation and the needs of the market. The market for each drug listed by its generic name/active ingredient and approved indication(s) is also analyzed in this report. A detailed analysis of the structure of the orphan drug industry has been conducted. Revenues are broken down by region drug type (i.e., biological and nonbiological), active ingredient and area of medical application. Sales figures are estimated for the five-year period from 2012 through 2017. Applications for orphan drugs are also discussed in the report, with an emphasis on the … Continue reading →